Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Sells $1,971,169.88 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 5,318 shares of the business’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total value of $1,971,169.88. Following the transaction, the executive vice president now directly owns 298 shares of the company’s stock, valued at approximately $110,456.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Myriam Curet also recently made the following trade(s):

• On Friday, March 1st, Myriam Curet sold 1,605 shares of Intuitive Surgical stock. The shares were sold at an average price of $383.48, for a total value of $615,485.40.
• On Monday, February 12th, Myriam Curet sold 481 shares of Intuitive Surgical stock. The shares were sold at an average price of $386.09, for a total value of $185,709.29.
• On Friday, January 26th, Myriam Curet sold 4,318 shares of Intuitive Surgical stock. The shares were sold at an average price of $370.15, for a total value of $1,598,307.70.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $373.12 on Friday. The stock has a market capitalization of $132.35 billion, a price-to-earnings ratio of 67.35, a PEG ratio of 4.83 and a beta of 1.36. Intuitive Surgical, Inc. has a 52-week low of $254.85 and a 52-week high of $403.76. The stock’s 50 day moving average price is $386.26 and its two-hundred day moving average price is $345.39.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same period in the prior year, the business earned $1.00 EPS. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 4.84 EPS for the current year.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on ISRG. Jefferies Financial Group upped their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research note on Friday, April 19th. Barclays upped their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research note on Thursday, January 25th. Mizuho upped their price objective on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research note on Thursday, January 25th. Piper Sandler upped their target price on Intuitive Surgical from $425.00 to $435.00 and gave the company an “overweight” rating in a report on Friday, April 19th. Finally, Raymond James upped their target price on Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a report on Thursday, January 25th. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $396.17.

Hedge Funds Weigh In On Intuitive Surgical

A number of large investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of Intuitive Surgical by 0.7% in the 3rd quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock worth $8,730,184,000 after purchasing an additional 196,316 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in shares of Intuitive Surgical by 1.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock worth $5,726,102,000 after purchasing an additional 272,741 shares in the last quarter. Edgewood Management LLC lifted its holdings in shares of Intuitive Surgical by 7.9% in the 4th quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock worth $1,731,016,000 after purchasing an additional 374,667 shares in the last quarter. Jennison Associates LLC raised its position in Intuitive Surgical by 6.4% in the 3rd quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock valued at $1,340,205,000 after buying an additional 274,692 shares during the last quarter. Finally, Fisher Asset Management LLC raised its position in Intuitive Surgical by 2.0% in the 4th quarter. Fisher Asset Management LLC now owns 4,494,373 shares of the medical equipment provider’s stock valued at $1,516,222,000 after buying an additional 88,977 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.